Mulina Tablet 600 mg, containing the active ingredient Lefamulin Acetate, is a high-potency antibiotic designed to treat specific bacterial infections. Lefamulin is a pleuromutilin antibiotic that works by inhibiting bacterial protein synthesis, effectively stopping the growth of bacteria responsible for respiratory tract infections. This novel antibiotic is especially utilized for the treatment of community-acquired bacterial pneumonia (CABP) in adults and provides an important option for patients where other antibiotics may not be suitable.

Key Features and Benefits
• Active Ingredient: Lefamulin Acetate 600 mg per tablet
• Antibacterial Action: Targets a wide range of Gram-positive and atypical bacteria responsible for respiratory infections
• Novel Mechanism: Pleuromutilin class antibiotic that binds to the 50S ribosomal subunit, disrupting bacterial protein synthesis
• Oral Administration: Convenient once-daily tablet form for outpatient therapy
• Broad Spectrum: Effective against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications
Mulina Tablet 600 mg is primarily indicated for the treatment of community-acquired bacterial pneumonia (CABP) in adults. CABP is a lung infection contracted outside of a hospital setting and is commonly caused by bacterial pathogens. Symptoms of CABP include cough, fever, shortness of breath, chest pain, and fatigue. This antibiotic provides an effective treatment option that can be administered orally, which supports improved patient compliance and ease of therapy.

Mechanism of Action
Lefamulin, the active moiety of Mulina Tablet, belongs to the pleuromutilin class of antibiotics. Its unique mechanism involves binding to the peptidyl transferase center of the 50S bacterial ribosomal subunit. This binding inhibits bacterial protein synthesis, preventing the bacteria from producing essential proteins needed for growth and replication. By halting these critical processes, Lefamulin effectively eliminates susceptible bacterial pathogens.

Dosage and Administration
The recommended dose of Mulina Tablet 600 mg is typically one tablet taken orally every 12 hours — or as directed by a qualified healthcare professional. It should be taken with or without food based on tolerability and medical advice. It is essential that patients complete the full prescribed course, even if symptoms improve before the course ends, to ensure the infection is fully treated and reduce the risk of antibiotic resistance.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions
Before initiating therapy with Mulina Tablet 600 mg, patients should inform their healthcare provider about any existing medical conditions, allergies, or other medications they are taking. Common side effects may include gastrointestinal discomfort, nausea, diarrhea, or headache. Serious side effects are rare but may include allergic reactions or liver function abnormalities. Regular monitoring by a healthcare professional is recommended if treatment is prolonged.

Drug Interactions and Contraindications
Mulina Tablet should be used with caution in patients taking medications that affect heart rhythm or interact with the cytochrome P450 system. It is contraindicated in individuals with known hypersensitivity to Lefamulin or any component of the formulation. Pregnant or breastfeeding women should consult a healthcare provider before use to assess potential risks and benefits.

Conclusion
Mulina Tablet 600 mg (Lefamulin Acetate) offers a modern, effective antibiotic option for adults suffering from community-acquired bacterial pneumonia. With its unique mechanism of action, convenient oral formulation, and broad spectrum of activity, it represents a valuable tool in combating respiratory bacterial infections, supporting improved patient outcomes and compliance.